Your browser doesn't support javascript.
loading
Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma.
Vigneron, Nicolas; Vernon, Mégane; Meryet-Figuière, Matthieu; Lambert, Bernard; Briand, Mélanie; Louis, Marie-Hélène; Krieger, Sophie; Joly, Florence; Lheureux, Stéphanie; Blanc-Fournier, Cécile; Gauduchon, Pascal; Poulain, Laurent; Denoyelle, Christophe.
Afiliação
  • Vigneron N; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Vernon M; UNICANCER, Cancer Center F. Baclesse, Caen, France.
  • Meryet-Figuière M; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Lambert B; UNICANCER, Cancer Center F. Baclesse, Caen, France.
  • Briand M; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Louis MH; UNICANCER, Cancer Center F. Baclesse, Caen, France.
  • Krieger S; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Joly F; UNICANCER, Cancer Center F. Baclesse, Caen, France.
  • Lheureux S; CNRS, Normandy Delegation, France.
  • Blanc-Fournier C; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Gauduchon P; UNICANCER, Cancer Center F. Baclesse, Caen, France.
  • Poulain L; Normandie Université, UNICAEN, Inserm U1086 ANTICIPE, Biology and Innovative Therapeutics for Ovarian Cancer (BioTICLA), Caen, France.
  • Denoyelle C; UNICANCER, Cancer Center F. Baclesse, Caen, France.
Clin Chem ; 66(2): 352-362, 2020 02 01.
Article em En | MEDLINE | ID: mdl-32040573
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs / Ácidos Nucleicos Livres Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Chem Assunto da revista: QUIMICA CLINICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs / Ácidos Nucleicos Livres Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Clin Chem Assunto da revista: QUIMICA CLINICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França